Growth factors, adiponectin, leptin and body mass index in pre-pubertal children born large for gestational age

A S Challa1, E N Evagelidou, V I Giapros

  • 1Pediatric Research Laboratory, Child Health Department, University of Ioannina, Ioannina, Greece.

Insights

Children born large for gestational age (LGA) show altered insulin resistance and lower IGFBP-3 levels compared to appropriate for gestational age (AGA) peers. Severity of overgrowth correlates with insulin resistance in LGA children.

Area of Science:

  • Pediatric Endocrinology
  • Growth Hormone Axis
  • Metabolic Health

Background:

  • Children born large for gestational age (LGA) may experience altered metabolic and endocrine profiles.
  • The insulin-like growth factor (IGF) axis plays a crucial role in growth and metabolism.
  • Understanding these differences is vital for monitoring long-term health outcomes.

Purpose of the Study:

  • To investigate potential differences in the IGF axis between pre-pubertal children born LGA and those born appropriate for gestational age (AGA).
  • To explore the relationship between birth weight percentile and endocrine/metabolic markers in LGA children.

Main Methods:

  • A cohort of 98 non-obese pre-pubertal children (5.5-8 years) was studied, including 37 LGA and 61 AGA.
  • Measurements included total and free IGF-I, IGFBP-1, IGFBP-3, leptin, adiponectin, glucose, and insulin.
  • Insulin resistance was assessed using the HOMA-IR index.

Main Results:

  • IGF-I and IGFBP-1 levels were similar between LGA and AGA groups.
  • Children born LGA exhibited significantly lower IGFBP-3 levels compared to AGA children.
  • LGA children showed higher fasting glucose, insulin, and HOMA-IR index, indicating increased insulin resistance, particularly in those with higher birth weight percentiles.
  • Adiponectin levels were elevated in the higher percentile LGA subgroup.

Conclusions:

  • The IGF axis, except for IGFBP-3, does not significantly differ in pre-pubertal children born LGA versus AGA.
  • Lower IGFBP-3 levels are a notable finding in LGA children.
  • The degree of intrauterine overgrowth in LGA children is associated with markers of insulin resistance.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...